BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Cambridge NeuroScience Incorporated

Cambridge NeuroScience Incorporated is a biopharmaceutical company engaged in the discovery and development of proprietary pharmaceuticals to prevent or treat severe disorders of, or injuries to, the nervous system.

Cambridge NeuroScience is focused in two areas of research and development: (i) ion-channel blockers to prevent or treat brain damage resulting from stroke and other forms of brain ischemia, as well as for the treatment or prevention of neuropathic pain, glaucoma, spinal cord injury, Parkinson's disease, multiple sclerosis ("MS") and peripheral neuropathies, and (ii) growth factors for the treatment of MS and peripheral neuropathies.


Contact Details:
333 Providence Highway
Norwood
MA
02062
United States of America
Tel:781-255-6700
Fax:781-255-6711
Email:
WWW:

www.cambneuro.com/




Loading...

Recent Publications by Cambridge NeuroScience Incorporated:

Neuregulin signaling in brain injury and in animal models of ischemia.
The identification and characterization of a potentially...
18th March, 2000
Cambridge NeuroScience, Inc., Massachusetts 02139, USA. Ann N Y Acad Sci. 1999;890:355.

BioNews Results for Cambridge NeuroScience Incorporated:

Life Sciences: Scientists at University of Glasgow, Department of Psychology describe research in life science
NewsRX:  Aug 19 2008 8:06PM Matching: cambridge neuroscience
Life Sciences: Data on life sciences in adolescents reported by researchers at Haskins Laboratories
NewsRX:  Aug 18 2008 9:27AM Matching: cambridge neuroscience
Data on life sciences in adolescents reported by researchers at Haskins Laboratories
NewsRX:  Aug 18 2008 8:45AM Matching: cambridge neuroscience
Blocking Drug-Related Memories May Prevent Relapses
MedicineNet.com:  Aug 16 2008 3:39AM Matching: cambridge neuroscience
Blocking Drug-Related Memories May Prevent Relapses
National Womens Health Information Center:  Aug 13 2008 6:22PM Matching: cambridge neuroscience
Promote your company here: BioNewsCast - Press Release Distribution

View more Cambridge NeuroScience Incorporated news.

Cambridge NeuroScience Incorporated Patents:

US Patent No.Title
5298657 Preparation of substituted guanidines
5670519 Acenaphthyl-substituted guanidines and methods of use thereof
5672608 Acenaphthyl substituted guanidines and methods of use thereof
5677348 Substituted aminoguanidines and methods of use thereof
5681568 Device for delivery of substances and methods of use thereof

View more Cambridge NeuroScience Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 174 times since April 2007, the link to the organisation's website has been followed 43 times

Recent Search Terms used to find this page: cambridge neuroscience massachusetts | neuroscience | .

Search for more companies in Norwood

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cambridge NeuroScience Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.